Canaccord Genuity Group Has Lowered Expectations for Aspen Aerogels (NYSE:ASPN) Stock Price

Aspen Aerogels (NYSE:ASPN) had its price target decreased by analysts at Canaccord Genuity Group from $20.00 to $15.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the construction company’s stock. Canaccord Genuity Group’s price target suggests a potential upside of 65.75% from the stock’s current price.

Other research analysts have also issued research reports about the company. Seaport Res Ptn lowered Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Saturday, February 8th. Roth Mkm cut their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Piper Sandler dropped their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Barclays dropped their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $26.33.

Aspen Aerogels Stock Up 0.6 %

Shares of Aspen Aerogels stock opened at $9.05 on Friday. The stock’s 50-day moving average is $12.36 and its 200 day moving average is $18.63. The firm has a market cap of $742.55 million, a price-to-earnings ratio of 905.91 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a one year low of $8.43 and a one year high of $33.15.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 5.06% and a net margin of 0.36%. Equities research analysts anticipate that Aspen Aerogels will post 0.12 EPS for the current year.

Institutional Trading of Aspen Aerogels

A number of institutional investors and hedge funds have recently modified their holdings of ASPN. AlphaQuest LLC increased its position in shares of Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after acquiring an additional 3,998 shares during the last quarter. nVerses Capital LLC increased its position in shares of Aspen Aerogels by 45.0% during the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after acquiring an additional 1,800 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $164,000. Journey Strategic Wealth LLC purchased a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $178,000. Finally, Ballentine Partners LLC increased its position in shares of Aspen Aerogels by 19.2% during the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock valued at $189,000 after acquiring an additional 2,565 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.